HomeVRCA • NASDAQ
add
Verrica Pharmaceuticals Inc
Previous close
$1.68
Day range
$1.65 - $1.75
Year range
$1.65 - $11.40
Market cap
72.11M USD
Avg Volume
1.01M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 5.18M | 2,744.51% |
Operating expense | 16.52M | 178.29% |
Net income | -17.19M | -56.38% |
Net profit margin | -331.97 | 94.50% |
Earnings per share | -0.37 | -54.17% |
EBITDA | -14.95M | -30.21% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 31.93M | -42.09% |
Total assets | 52.01M | -16.38% |
Total liabilities | 65.31M | 860.30% |
Total equity | -13.30M | — |
Shares outstanding | 42.67M | — |
Price to book | -5.42 | — |
Return on assets | -64.26% | — |
Return on capital | -93.91% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -17.19M | -56.38% |
Cash from operations | -16.36M | -250.35% |
Cash from investing | -11.00K | 81.36% |
Cash from financing | -640.00K | -661.90% |
Net change in cash | -17.01M | -253.47% |
Free cash flow | -10.74M | -996.91% |
About
CEO
Founded
2013
Headquarters
Website
Employees
100
